Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Resolvins suppress tumor growth and enhance cancer therapy.

Autor: Sulciner ML; Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.; Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA., Serhan CN; Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA cserhan@bwh.harvard.edu., Gilligan MM; Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.; Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA., Mudge DK; Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.; Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA., Chang J; Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.; Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA., Gartung A; Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.; Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA., Lehner KA; Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.; Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA., Bielenberg DR; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA., Schmidt B; Department of Pathology, Boston Children's Hospital, Harvard Medical School, Boston, MA., Dalli J; Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Greene ER; Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.; Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA., Gus-Brautbar Y; Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.; Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA., Piwowarski J; Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.; Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA., Mammoto T; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA., Zurakowski D; Department of Anesthesia, Boston Children's Hospital, Harvard Medical School, Boston, MA.; Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA., Perretti M; The William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University of London, London, England, UK., Sukhatme VP; Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA., Kaipainen A; Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Kieran MW; Division of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA mark_kieran@dfci.harvard.edu.; Department of Pediatric Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA., Huang S; Institute of Systems Biology, Seattle, WA sui.huang@systemsbiology.org., Panigrahy D; Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA dpanigra@bidmc.harvard.edu.; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.; Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.

Publikováno v: The Journal of experimental medicine [J Exp Med] 2018 Jan 02; Vol. 215 (1), pp. 115-140. Date of Electronic Publication: 2017 Nov 30.

[Structure determination of dimeric 1,3-dimethyl-uracils by 1 H-NMR-spectroscopy].

Autor: Fahr E, Maul P, Lehner KA, Scheutzow D

Publikováno v: Zeitschrift fur Naturforschung. Teil B. Anorganische Chemie, organische Chemie, Biochemie, Biophysik, Biologie [Z Naturforsch B Anorg Chem Org Chem Biochem Biophys Biol] 1972 Dec; Vol. 27 (12), pp. 1481-4.